Burrows Scott L
Reporting owner on Forms 3, 4 and 5, CIK 1853327.
Burrows Scott L reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-02.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Spyre Therapeutics, Inc. CIK 1636282 | officer (Chief Financial Officer) | 1 | 2026-10-02 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | M exercised | +7,500 | $14.5 | 87,262 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -600 | $89.07 | 86,662 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -1,500 | $90.27 | 85,162 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -2,100 | $91.92 | 83,062 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -3,071 | $92.95 | 79,991 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -229 | $93.57 | 79,762 | Form 4 |
| Spyre Therapeutics, Inc. Stock Option (Right to Buy), derivative | 2026-10-01 | M exercised | -7,500 | $0 | 312,357 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-09-30 | M exercised | +17,500 | $14.5 | 97,262 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-09-30 | S sold | -17,500 | $89.89 | 79,762 | Form 4 |
| Spyre Therapeutics, Inc. Stock Option (Right to Buy), derivative | 2026-09-30 | M exercised | -17,500 | $0 | 319,857 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001636282-26-000117 | Spyre Therapeutics, Inc. | 2026-10-02 |